CVD Data to be Standardized Across Europe

Budgets are becoming tighter and health systems are under pressure to address the increasing burden of chronic diseases. Tackling chronic diseases requires up to date information on disease prevalence and risk factors but Europe currently lacks data on cardiovascular disease (CVD) that is standardized and can be compared.

The European Society of Cardiology (ESC) is therefore creating a task force on CVD data standardization so that data from different registries can be compared. The ESC will also collaborate with the PAtient REgistries iNiTiative (PARENT) Joint Action (1) to create an inventory of registries - this will help the cardiology community find existing data and avoid duplication.

The moves follow a meeting of cardiology organizations and experts initiated by the ESC in Brussels, Belgium, to discuss the need for coordination and standardization of CVD data in Europe (2).

The ESC task force on CVD data standardization will build on Cardiology Audit and Registration Data Standards (CARDS). ESC experts were instrumental in CARDS, which was an initiative of the Irish Ministry of Health & Children and co-funded by the European Union (EU) in 2004. CARDS aimed to standardize the definitions used in the collection of CVD data, and resulted in three data sets for three sub-specialties of cardiology: percutaneous coronary intervention, clinical electrophysiology and acute coronary syndromes.

Professor Frans Van de Werf (Leuven, Belgium), who was the instigator of the Brussels workshop, said: "CARDS is nearly 10 years old and should be updated. We need to get more countries and studies involved in implementing it so that everyone can benefit from standardized, comparable data on cardiovascular disease."

Professor Van de Werf said: "The inventory of registries will provide a single entry point for health professionals, researchers and policy makers looking for real life data on cardiovascular diseases. It will also avoid duplication of data collection in Europe. Countries will be able to use country-level data from European registries, rather than establishing their own registry. This will save valuable time and money."

1. Joint Actions are projects carried out by the European Union (EU) and one or more Member States or by the EU and the competent authorities of other countries participating in the health programme.
The PARENT Joint Action was established to support cross-border use of patient registry data for public health and research purposes including health technology assessment, pricing, and vigilance and safety. It brings support to EU member states for the development and governance of patient registries.

2. The meeting was attended by:
British Heart Foundation Health Promotion Research Group (BHFHPRG), University of Oxford (UK)
European Commission, DG SANCO (Belgium)
European Heart Network (Belgium)
European Organisation for Research & Treatment of Cancer (Belgium)
European Organisation for Research and Treatment of Cancer (EORTC) (Belgium)
European Society of Cardiology (France)
National Institute for Health & Welfare (Finland)
National Institute of Public Health (Slovenia)
Organisation for Economic Co-operation and Development (OECD)
Universities of Ghent and Brussels (Belgium)

About the European Society of Cardiology
The European Society of Cardiology (ESC) represents 80,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...